AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds

AstraZeneca’s deal with CSPC Pharmaceutical Group includes a Phase 1-ready obesity drug that hits the same targets as Eli Lilly’s obesity drug Zepbound, but with monthly dosing. The new collaboration builds on an existing drug R&D relationship between the two companies. The post AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC…

Read More

Recent Trends in GLP-1 Use and Spending in Medicare

Ahead of the Trump administration’s planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicare’s negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMS’s Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being…

Read More

Elementor #572823

Get Accurate Results with Blood Test at Home Table of Contents Introduction to Home Blood Testing You need not wait several days for a doctor’s appointment or spend hours waiting at diagnostic labs. These modern test kits allow you to monitor important health markers right from your home, with accurate results delivered quickly and privately….

Read More